What COVID-19 vaccines are available to kids in the U.S.? In the U.S., COVID-19 vaccines are available to children based on their age. The number of shots ... How did the FDA determine the ...
Opens in a new tab or window The updated monovalent XBB.1.5 COVID-19 vaccines were effective ... 1 or future strains," the authors wrote. The FDA's Vaccines and Related Biological Products ...
Cue Health, headquartered in San Diego, received emergency use FDA authorization for two COVID-19 tests early in the pandemic to help people detect if they were infected with the virus.
Novavax Awaits FDA Decision on Whether Its Next COVID Shot ... Since 2022, regulators have asked vaccine makers to design new versions of the COVID shots to better target currently circulating ...
Thousands believe COVID ... shots? U.S. regulators strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The FDA said ...
advised consumers Monday not to use over-the-counter COVID-19 tests by Cue Health and to throw them out. The FDA issued a warning letter Thursday to the California-based company over findings of a ...
The Food and Drug Administration warned consumers Monday to not use Cue Health’s at-home Covid-19 tests. This follows an FDA warning letter to the company last week that said Cue was not ...
An inspection revealed Cue Health made changes to the tests that reduce their reliability to detect SARS-CoV-2 virus. The Food and Drug Administration (FDA) has issued a warning letter to Cue ...
Check your cabinets. The U.S. Food and Drug Administration (FDA) warned consumers and healthcare professionals Monday that COVID-19 tests from Cue Health may give you false results and should be ...
More than a third of COVID-19 cases in the ... that vaccine manufacturers produce shots targeted at the JN.1 variant for next season. A panel of the FDA's own vaccine experts were scheduled ...
opens new tab will only be able to offer a COVID-19 vaccine ... said it could make the shots in 100 days. Moderna and Pfizer each told Reuters they are waiting for the FDA's advisers to discuss ...